Leinwand, B., Johnsrud, M., Nguyen, A., Meyer, J. and Johnson, K. (2020) A Ready-to-Use Liquid Glucagon for Treatment of Severe Hypoglycemia Demonstrates Reduced Healthcare Payer Costs in a Budget Impact Model. Journal of Medical Economics, 23, 744-750.
https://doi.org/10.1080/13696998.2020.1742131

has been cited by the following article:

• TITLE: Evolution in Overcoming Barriers in Management of Diabetes: Hypoglycemia

  AUTHORS: Sonal S. Banzal, Subodh Banzal, Udaya M. Kabadi

  KEYWORDS: Diabetes, Hypoglycemia, Recognition, Prevention, Treatment

  JOURNAL NAME: Journal of Diabetes Mellitus, Vol.11 No.5, November 16, 2021

  ABSTRACT: The main objective of management of diabetes focuses on eliminating symptoms of hyperglycemia, preventing hyperglycemic and other metabolic complications, delaying onset of chronic deleterious microvascular disorders and reducing macrovascular risk. However, iatrogenic hypoglycemia remains a major limiting factor in attaining and maintaining desirable glycemic targets. Hypoglycemia is defined as plasma glucose concentration